WAPNICK PAMELA (Chief Financial Officer) sold 0.8% of their position (1.58K shares) of METAGENOMI THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/8/2025ACC: 0001193125-25-310953
Officer· Chief Financial Officer
Since Mar 2026
-1.58K
Net shares
Net seller
$2.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.58K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.58K
Price / share
$1.77
Trade value
$2.79K
% of position
0.8%
12/5/2025
190.53K→188.96K
Total
Net shares
−1.58K
Net value
-$2.79K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/5/2025 | S · Sale | −1.58K | $1.77 | $2.79K | 0.8% | 190.53K | 188.96K |
| Total | −1.58K | -$2.79K | ||||||
Derivative Transactions0
No derivative transactions reported